Stock Analysis of Achieve Life Sciences Inc (ACHV) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ACHV
Close 5.00
Change -0.070 / 1.38 %
Volume 108758
Vol Change -47890.00 / 30.57 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of Achieve Life Sciences Inc
PE (TTM)

-2019.76

Very Poor
Price / Book

4436.05

Very Poor
Price / Sales

0

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

171706 K

Enterprise Value

172885 K

ROA (TTM)

-83.56

Very Poor
ROE (TTM)

-219.63

Very Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

16.01 %

-35571.00 K
Debt to Equity

-11.55

Very Poor
Altman Z Score

-12.88

Very Poor
Quick Ratio

0

Poor
Cash Ratio

0.747

Not Good


Highs/Lows of Achieve Life Sciences Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week4.61 8.46 % 1.54 % 5.35874.6416-May-2413-May-24
Two Week4.735 5.60 % 3.42 % 5.35874.3716-May-2410-May-24
One Month4.57 9.41 % 5.60 % 5.35874.3516-May-2423-Apr-24
Three Month4.32 15.74 % 5.95 % 5.35873.8216-May-2422-Feb-24
Six Months5.3 5.66 % 17.48 % 5.983.0328-Nov-2312-Dec-23
One year7.65 34.64 % 27.52 % 8.373.0322-May-2312-Dec-23
Two year6.83 26.79 % 29.70 % 10.252.011-May-2309-Nov-22
Five year69.8 92.84 % 85.46 % 10.252.011-May-2309-Nov-22
Ten year8448.0 99.94 % 182.41 % 9526.02.028-May-1409-Nov-22


Technical View of Achieve Life Sciences Inc
RSI

60.24

Neutral
MACD

0.137

Bullish
ADX

12.41

Bullish
Super Trend

4.47

Mild Bullish
Williams %R

-35.92

Neutral
CCI

119.12

Mild Bearish


EMA 5

4.98

Bullish
EMA 15

4.80

Strong Bullish
EMA 50

4.61

Strong Bullish
EMA 100

4.56

Mild Bullish
SMA 100

4.48

Bullish
SMA 200

4.53

Whipsaw
SMA 5 / 20

5.02 / 4.69

Strong Bullish
SMA 15 / 50

4.74 / 4.57

Mild Bullish
SMA 50 / 200

4.57 / 4.53

Mild Bullish




Charts of Achieve Life Sciences Inc


Returns of Achieve Life Sciences Inc with Peers
Period / StockACHVBTMDKODSCPH
1 Week8.46%-6.05%-8.59%6.03%
1 Mth9.41%4.17%-8.33%7.47%
3 Mth15.74%22.86%-39.00%-17.25%
6mth-5.66%15.69%32.53%-9.52%
1 Year-34.64%-1.37%-41.39%-57.85%
2 Year-26.79%-42.33%-45.99%-0.628%
5 Years-92.84%--63.37%35.71%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Achieve Life Sciences Inc with Peers
Ratio / StockACHVBTMDKODSCPH
PE-2019.76302460-0.744-1595.36
P/B4436.05-516.710.5621840.09
ROA-83.560.068-43.23-55.43
ROE-219.630-75.55-115.34
Debt To Equity-11.55-3.850.03681.05
Revenue0
% 		184142 K
11.63 % 		0
% 		7497.00 K
263.40 %
Net Income-35571.00 K
16.01 % 		-2796.00 K
188.54 % 		-271423.00 K
79.23 % 		-50246.00 K
36.40 %


Technicals of Achieve Life Sciences Inc with Peers
Technical / StockACHVBTMDKODSCPH-
ADX12.4113.3015.9716.93
CMF-0.066-0.148-0.227-0.0314
MFI65.0854.6954.0055.79
RSI60.2447.2537.1251.18
MACD Abv SignalTrueFalseTrueTrue
Price Above 50 MATrueFalseFalseFalse-
Price Above 200 MATrueTrueFalseFalse-


About : Achieve Life Sciences Inc

Address : 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1
Tel : 604 210 2217
URL : https://www.achievelifesciences.com
Code : ACHV, ISIN : US0044685008, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 13_Oct_1995
Employee Count : 22

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.


Note : All Data Generated at the End of Trading Hours (EOD Data)